Alexion: 4Q Earnings Snapshot

February 4, 2019

BOSTON (AP) _ Alexion Pharmaceuticals Inc. (ALXN) on Monday reported a fourth-quarter loss of $45 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Boston-based company said it had a loss of 20 cents. Earnings, adjusted for one-time gains and costs, came to $2.14 per share.

The results beat Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.83 per share.

The drugmaker posted revenue of $1.13 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $1.06 billion.

For the year, the company reported profit of $77.6 million, or 35 cents per share. Revenue was reported as $4.13 billion.

Alexion expects full-year earnings in the range of $9.10 to $9.30 per share, with revenue in the range of $4.63 billion to $4.7 billion.

Alexion shares have climbed 30 percent since the beginning of the year, while the Standard & Poor’s 500 index has increased 8 percent. The stock has increased nearly 9 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALXN at https://www.zacks.com/ap/ALXN

Update hourly